Ipca Laboratories Ltd (IPCALAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 950228, "name": "Ipca Labs", "stock_name": "Ipca Labs", "full_name": "Ipca Laboratories Ltd", "name_url": "stocks-analysis/ipca-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,551.75", "chg": -6.15, "chgp": "-0.39%", "dir": -1, "prev_price": "1,557.90", "mcapval": "39,953.00 Cr", "mcap": "Mid Cap", "scripcode": "524494", "symbol": "IPCALAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE571A01038", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "2.54 lacs", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Ipca Laboratories Gains 1.38%: 3 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-138-3-key-factors-driving-the-weeks-momentum-3983264", "imagepath": "", "date": "2026-05-09 14:04:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>4 May:</strong> Week opens at ₹1,530.60</p>\n <p><strong>6 May:</strong> MarketsMOJO upgrades Ipca Labs to Buy on strong fundamentals</p>\n <p><strong>7 May:</strong> Technical momentum shifts to bullish, stock closes at ₹1,563.70 (+1.28%)</p>\n <p><strong>8 May:</strong> Mildly bullish technical signals as stock closes at ₹1,551.75 (-0.39%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,530.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"..." }, { "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3980786", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_technicaldot_3980786.png", "date": "2026-05-08 08:04:25", "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a slight dip in the stock price, the company’s technical indicators present a complex picture that investors should carefully analyse to gauge future price movements." }, { "title": "Ipca Laboratories Ltd Upgraded to Buy by MarketsMOJO on Strong Fundamentals and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-upgraded-to-buy-by-marketsmojo-on-strong-fundamentals-and-technicals-3979062", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_mojoScore_3979062.png", "date": "2026-05-07 08:21:47", "description": "Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The mid-cap pharmaceutical company’s recent performance and market positioning have prompted this positive reassessment, signalling renewed investor confidence and potential for sustained growth." }, { "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-3978914", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_technicaldot_3978914.png", "date": "2026-05-07 08:05:33", "description": "Ipca Laboratories Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside robust price performance that outpaces the broader Sensex index over multiple time frames." }, { "title": "Ipca Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-hold-3975723", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_mojoScore_3975723.png", "date": "2026-05-05 10:10:34", "description": "Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Ipca Laboratories Gains 6.14%: 2 Key Factors Driving This Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-614-2-key-factors-driving-this-weeks-momentum-3962491", "imagepath": "", "date": "2026-04-25 14:02:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Apr 20:</strong> Stock opens at Rs.1,468.50 with marginal gain</p>\n <p><strong>Apr 22:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>Apr 22:</strong> Valuation shifts signal changing market sentiment</p>\n <p><strong>Apr 24:</strong> Stock closes at Rs.1,558.15, up 2.31% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,468.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,558.15..." }, { "title": "Ipca Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-hold-3960599", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_mojoScore_3960599.png", "date": "2026-04-24 10:10:31", "description": "Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3957087", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_technicaldot_3957087.png", "date": "2026-04-22 08:03:52", "description": "Ipca Laboratories Ltd has exhibited a subtle shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, as reflected in recent technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s performance relative to the Sensex and its own historical returns offers a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Ipca Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-signal-changing-market-sentiment-3956800", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_valuationdot_3956800.png", "date": "2026-04-22 08:01:26", "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade from Buy to Hold as of 1 April 2026. With its price-to-earnings (P/E) ratio rising to 36.07 and price-to-book value (P/BV) at 5.06, the stock now trades in the 'expensive' category relative to its historical averages and peer group, signalling a more cautious stance for investors." } ], "total": 954, "sid": "950228", "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228" }, "announcements": [ { "caption": "Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend", "datetime": "04-May-2026", "details": "Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Standalone and Consolidated Financial Results for 4th quarter and financial year ended 31st March 2026 and Dividend", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "08-Apr-2026", "details": "The Company has enclosing herewith certificate received from RTA under reg 74 (5) of DP Regulations for the quarter ended 31.03.2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "02-Apr-2026", "details": "Newspaper Notice issued by the Company regarding transfer of physical shares.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "29 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25", "dt": "2025-08-05", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22", "dt": "2022-01-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

4 May: Week opens at ₹1,530.60

6 May: MarketsMOJO upgrades Ipca Labs to Buy on strong fundamentals

7 May: Technical momentum shifts to bullish, stock closes at ₹1,563.70 (+1.28%)

8 May: Mildly bullish technical signals as stock closes at ₹1,551.75 (-0.39%)

Week Open

₹1,530.60

Week Close

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-05-08 08:04:25

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a slight dip in the stock price, the company’s technical indicators present a complex picture that investors should carefully analyse to gauge future price movements.

Read full news article

Ipca Laboratories Ltd Upgraded to Buy by MarketsMOJO on Strong Fundamentals and Technicals

2026-05-07 08:21:47

Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The mid-cap pharmaceutical company’s recent performance and market positioning have prompted this positive reassessment, signalling renewed investor confidence and potential for sustained growth.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-07 08:05:33

Ipca Laboratories Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside robust price performance that outpaces the broader Sensex index over multiple time frames.

Read full news article

Ipca Laboratories Ltd is Rated Hold

2026-05-05 10:10:34

Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Ipca Laboratories Gains 6.14%: 2 Key Factors Driving This Week’s Momentum

2026-04-25 14:02:26

Key Events This Week

Apr 20: Stock opens at Rs.1,468.50 with marginal gain

Apr 22: Technical momentum shifts amid mixed indicator signals

Apr 22: Valuation shifts signal changing market sentiment

Apr 24: Stock closes at Rs.1,558.15, up 2.31% on the day

Read full news article

Ipca Laboratories Ltd is Rated Hold

2026-04-24 10:10:31

Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-22 08:03:52

Ipca Laboratories Ltd has exhibited a subtle shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, as reflected in recent technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s performance relative to the Sensex and its own historical returns offers a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Ipca Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment

2026-04-22 08:01:26

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade from Buy to Hold as of 1 April 2026. With its price-to-earnings (P/E) ratio rising to 36.07 and price-to-book value (P/BV) at 5.06, the stock now trades in the 'expensive' category relative to its historical averages and peer group, signalling a more cautious stance for investors.

Read full news article

View All News